Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.
Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP; TRAFFIC Study Group; TRANSPORT Study Group. Wainwright CE, et al. Among authors: ratjen f. N Engl J Med. 2015 Jul 16;373(3):220-31. doi: 10.1056/NEJMoa1409547. Epub 2015 May 17. N Engl J Med. 2015. PMID: 25981758 Free PMC article. Clinical Trial.
Cystic fibrosis.
Ratjen F, Döring G. Ratjen F, et al. Lancet. 2003 Feb 22;361(9358):681-9. doi: 10.1016/S0140-6736(03)12567-6. Lancet. 2003. PMID: 12606185 Review.
Inhalation of Moli1901 in patients with cystic fibrosis.
Grasemann H, Stehling F, Brunar H, Widmann R, Laliberte TW, Molina L, Döring G, Ratjen F. Grasemann H, et al. Among authors: ratjen f. Chest. 2007 May;131(5):1461-6. doi: 10.1378/chest.06-2085. Chest. 2007. PMID: 17494794 Clinical Trial.
New pulmonary therapies for cystic fibrosis.
Ratjen F. Ratjen F. Curr Opin Pulm Med. 2007 Nov;13(6):541-6. doi: 10.1097/MCP.0b013e3282efbc56. Curr Opin Pulm Med. 2007. PMID: 17901762 Review.
Emerging therapies for cystic fibrosis lung disease.
Grasemann H, Ratjen F. Grasemann H, et al. Among authors: ratjen f. Expert Opin Emerg Drugs. 2010 Dec;15(4):653-9. doi: 10.1517/14728214.2010.517746. Epub 2010 Sep 3. Expert Opin Emerg Drugs. 2010. PMID: 20812885 Review.
495 results